Adults with attention deficit hyperactivity disorder (ADHD) or severe ADHD symptoms who practiced microdosing with psychedelics reported increases in mindfulness after four weeks, according to new preliminary research published in Frontiers in Psychiatry. The findings underscore the importance of conducting future placebo-controlled studies to validate whether these observed changes can be replicated in a controlled…

In a recent study published in the Journal of Neuroscience, researchers found that individuals with Attention-Deficit/Hyperactivity Disorder (ADHD) show reduced motivation to engage in effortful activities, both cognitive and physical, which can be significantly improved with amphetamine-based medications.

THURSDAY, Nov. 30, 2023 (HealthDay News) — The presence of psychiatric comorbidity in young patients with attention-deficit/hyperactivity disorder (ADHD) is associated with a higher risk for being diagnosed with schizophrenia, according to a study published online Nov. 30 in JAMA Network Open.

CHICAGO — An artificial intelligence (AI) deep-learning model pinpointed significant differences in nine brain white matter tracts in adolescents with attention deficit-hyperactivity disorder (ADHD), researchers reported here.

Summary: Taking into account whether people believe they are receiving a real treatment or a fake one (placebo) could provide better insights that could help improve interventions for conditions such as depression and ADHD.

CNN — Long-term use of ADHD medications can raise the risk of cardiovascular disease in both children and adults, according to a study published Wednesday in JAMA Psychiatry. Experts say that the benefits of treatment still outweigh the risks for many, but heart heath should be carefully considered and monitored when making individual decisions.

Longer use of attention deficit-hyperactivity disorder (ADHD) medication was associated with an increased risk of cardiovascular disease, particularly hypertension and arterial disease, a nested case-control study from Sweden showed.

CLEVELAND, Ohio — The nationwide shortage of Adderall and related drugs, used to treat attention/deficit hyperactivity disorder, has passed the year mark with no end in sight. High demand — from increased access to the medication via telehealth to people with long COVID-19 using ADHD drugs — makes the situation worse.

4.1 million Brits are not treating their conditions due to NHS waiting lists and a lack of accessible treatment.

Recognition, response, and resilience will get them far in life.

GARNER, N.C. (WNCN) — Pharmacists at White Oak Pharmacy in Garner say some medications just aren’t coming in the door, specifically ones for ADHD patients. “Focalin and Concerta, those remain on backorder, which is a real problem for a lot of children in school right now that take those,” said owner Melissa Illig.

In a recent study published in Molecular Psychiatry, researchers from China examined the effect of two drugs used for the treatment of attention-deficit/hyperactivity disorder (ADHD)— methylphenidate (MPH) and atomoxetine (ATX)— on the Drosophila melanogaster brain at single-cell resolution.